Legal Representation
Attorney
Douglas T. Johnson
USPTO Deadlines
Next Deadline
1987 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-01-07)
Due Date
January 07, 2031
Grace Period Ends
July 07, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
25 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 26, 2025 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Jul 5, 2025 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Jul 5, 2025 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Apr 7, 2025 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Feb 15, 2025 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Jan 27, 2025 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Jan 26, 2025 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Jan 7, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jan 7, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 19, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 19, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 13, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 7, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 27, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 27, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 27, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 24, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Mar 29, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Mar 28, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Mar 10, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Mar 9, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 6, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 12, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Sep 7, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 31, 2023 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Viral systems, gene therapy systems, nucleic acid delivery systems, namely, viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes; pharmaceutical products for the treatment of neurodegenerative disease; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy; clinical medical reagents for use in gene therapy; pharmaceutical preparations, vaccines, prophylaxis products and other pharmaceutical products for use in gene therapy
Class 042
Research, product development and consultancy in the field of biotechnology, biologics and medical science; research and product development in the field of pharmaceutics
Class 044
Gene and nucleic acid delivery by viral vectors, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; consultancy in the field of pharmaceutics
Additional Information
Design Mark
The mark consists of the stacked wording "VECTORY THERAPEUTICS" in stylized dark blue lettering to the right of an incomplete circle comprised of green, light blue, and dark blue segments; inside this incomplete circle is a block letter "Y" comprised of green, light blue, and dark blue segments.
Color Claim
The colors blue and green are claimed as a feature of the mark.
Classification
International Classes
005
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"